References
- 1. Singh VK, Pokhariyal T, Tiwari AK - Transdermal drug delivery system for non-steroidial anti inflammatory drugs: a review. Indo Am J Pharm Res. 2013;3(4):3588-3604.
- 2. Rastogi V, Yadav P - Transdermal drug delivery system: an overview. Asian J Pharm. 2012;6(3):161-170.10.4103/0973-8398.104828
- 3. Premjeet S, Bilandi A, Sahil K, Akanksha M - Transdermal drug delivery system (patches), applications in present scenario. IJRPC. 2011;1(4):1139-1151.
- 4. Cristea AN - Tratat de farmacologie, Bucureşti, Ed. Medicală, 2009, 617-633.
- 5. Gopal V, Rose C, Prakash Yoganandam G, Subash P - A comprehensive review on transdermal drug delivery system. I J A P. 2014;4(4):211-216.
- 6. https://www.drugbank.ca/drugs/DB00814
- 7. Bartosova L, Bajgar J - Transdermal drug delivery in vitro using diffusion cells. Curr Med Chem. 2012;19:4671-4677.10.2174/09298671280330635822934776
- 8. Shingade GM, Aamer Q, Sabale PM, Grampurohit ND, Gadhave MV et al - Review on: recent trend on transdermal drug delivery system. JDDT. 2012;2(1):66-74.
- 9. Gaikwad AK - Transdermal drug delivery system: Formulation aspects and evaluation. Compr J Pharm Sci. 2013;1(1):1-10.
- 10. Patel DM, Kavitha K - Formulation and evaluation aspects of transdermal drug delivery system. Int J Pharm Sci Rev Res. 2011;6(2):83-90.
- 11. Saroha K, Yadav B, Sharma B - Transdermal patch: a discrete dosage form. Int J Curr Pharm Res. 2011;3(3):98-108.
- 12. Shirsand SB, Ladhane GM, Prathap S, Prakash PV - Design and evaluation of matrix transdermal patches of meloxicam. RGUHS J Pharm Sci. 2012;2(4):58-65.
- 13. Duan XD, Ji CJ, Nie L - Formulation and development of dendrimer-based transdermal patches of meloxicam for the management of arthritis. Trop J Pharm Res. 2015;14(4):583-590.10.4314/tjpr.v14i4.4
- 14. Yener G, Üner M, Gönüllü Ü, Yildririm S, Kilic P - Design of meloxicam and lornoxicam transdermal patches: preparation, physical characterization, ex vivo and in vivo studies. Chem Pharm Bull. 2010;58(11):1466-1473.10.1248/cpb.58.146621048338
- 15. Shaji J, Shah A - Development and characterization of tenoxicam encapsulated niosomes for enhanced transdermal delivery. IJPSR. 2016;7(1):307-315.
- 16. Nesseem D, Eid SF, El-Houseny SS - Development of novel transdermal self-adhesive films for tenoxicam, an anti-inflamatory drug. Life Sci. 2011;89:430-438.10.1016/j.lfs.2011.06.02621777594
- 17. Srivastava P, Kulkarni GT, Kumar M, Visht S - Design and evaluation of pectin based matrix for transdermal patches of meloxicam. JPRHC. 2010;2(3):244-247.
- 18. Antonoaea P, Todoran N, Rédai E, Ciurba A, Bogdan C, Moldovan M, Muntean DL - Evaluation of mechanical properties of nonsteroidal anti-inflammatory matrix type transdermal therapeutic systems. Acta Medica Marisiensis. 2017;63(2):56-61.10.1515/amma-2017-0011
- 19. ***ICH Validation of Analytical Procedures: Text and Methodology Q2 (R1), International Conference on Harmonization IFPMA, Geneva. 2005.
- 20. Csifo E, Croitoru MD, Fulop I, Muntean DL - Development of a HPLC-UV method for determination of meloxicam in human plasma and pharmaceutical dosage forms. Acta Medica Marisiensis. 2014;60(4):142-14510.2478/amma-2014-0031
- 21. Singh AK, García PL, Gomes FP, Kedor-Hackmann ERM, Santoro MIRM - Comparative study on two rapid and sensitive methods for quantitative determination of tenoxicam in tablets. Braz J Pharm Sci. 2007;43(4):615-622.
- 22. Sinha PK, Jeswani RM, Topagi KS, Damle MC - A validated RP-HPLC method for determination of Meloxicam in the Presence of its Impurities. Int J PharmTech Res. 2009;1(4):1051-1060.